MEDINCELL SA (MEDCL.PA) Stock Analyst Earnings Estimates
EPA:MEDCL - Euronext Paris - Matif - FR0004065605 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 9.889M 141.78% | 9.032M -8.67% | 25.419M 181.43% | 40.875M 60.80% | 88.855M 117.38% | 97.514M 9.75% | 116.85M 19.83% | 161.32M 38.06% | 156.15M -3.20% | 254.39M 62.91% | |
| EBITDA YoY % growth | -22.387M -0.40% | -19.125M 14.57% | N/A 52.79% | 25.827M 386.02% | 51.655M 100.00% | 49.662M -3.86% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.052M -1.00% | -20.844M 13.34% | -10.84M 47.99% | 17.15M 258.21% | 50.813M 196.29% | 49.662M -2.27% | 65.924M 32.75% | 107.51M 63.08% | 101.42M -5.66% | 195.74M 93.00% | |
| Operating Margin | -243.22% | -230.78% | -42.65% | 41.96% | 57.19% | 50.93% | 56.42% | 66.64% | 64.95% | 76.94% | |
| EPS YoY % growth | N/A -46.42% | N/A -13.12% | N/A 25.24% | 0.30 141.86% | 1.51 401.71% | 1.59 5.60% | 2.28 43.21% | 4.25 86.22% | 4.46 5.01% | 8.46 89.54% |
All data in EUR
| Q2 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.25 | -0.20 -50.54% |
| Revenue Q2Q % growth | 10.184M 18.14% | 12.509M -25.54% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -6.201M 17.64% | -4.692M 61.72% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.13 77.59% | -0.43 | 0.30 | 69.95% |
| Q4 2024 Q2Q % growth | -0.58 | -0.33 | -0.25 | -75.97% |
| Q1 2022 Q2Q % growth | -152.63% | -0.74 | % | |
| Q1 2021 Q2Q % growth | 64.60% | -0.29 | % | |
| Q1 2020 Q2Q % growth | 4.73% | -0.83 | % |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 16.799M 720.66% | 4.223M | 12.576M | 297.80% |
| Q2 2025 Q2Q % growth | 8.62M 23.41% | % | ||
| Q4 2024 Q2Q % growth | 2.047M -46.97% | 8.24M | -6.193M | -75.16% |
| Q2 2024 Q2Q % growth | 6.985M 15.84% | % | ||
| Q4 2023 Q2Q % growth | 3.86M 55.02% | % | ||
| Q2 2023 Q2Q % growth | 6.03M 276.88% | % | ||
| Q4 2022 Q2Q % growth | 2.49M -64.22% | % | ||
| Q2 2022 Q2Q % growth | 1.6M 30.08% | % | ||
| Q1 2022 Q2Q % growth | -41.44% | 11.828M | % | |
| Q4 2021 Q2Q % growth | 6.96M 673.33% | % | ||
| Q2 2021 Q2Q % growth | 1.23M -37.24% | % | ||
| Q1 2021 Q2Q % growth | 265.70% | 20.198M | % | |
| Q4 2020 Q2Q % growth | 900K 36.36% | % | ||
| Q2 2020 Q2Q % growth | 1.96M 151.28% | % | ||
| Q1 2020 Q2Q % growth | 74.32% | 5.523M | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | -26.47% | -26.47% |